JAAOS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Acad Orthop Surg, Vol 16, No 4, April 2008, 177-187.
© 2008 the American Academy of Orthopaedic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Altman, G. H.
Right arrow Articles by Richmond, J. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altman, G. H.
Right arrow Articles by Richmond, J. C.

The Use of Long-term Bioresorbable Scaffolds for Anterior Cruciate Ligament Repair

Gregory H. Altman, PhD, Rebecca L. Horan, PhD, Paul Weitzel, MD and John C. Richmond, MD

Dr. Altman is President and Chief Executive Officer, Serica Technologies, Inc, Medford, MA. Dr. Horan is Senior Director of Research and Development, Serica Technologies, Inc. Dr. Weitzel is Orthopaedic Surgeon, Boston Sports and Shoulder Center, Chestnut Hill, MA. Dr. Richmond is Chairman of Orthopaedic Surgery, New England Baptist Hospital, Boston, MA.

Dr. Altman or a member of his immediate family has received research or institutional support, has stock or stock options held in, and serves as a consultant to or is an employee of Serica Technologies, Inc. Dr. Horan or a member of her immediate family has stock or stock options held in and serves as a consultant to or is an employee of Serica Technologies, Inc. Dr. Weitzel or a member of his immediate family has stock or stock options held in and serves as a consultant to or is an employee of Serica Technologies, Inc. Dr. Richmond or a member of his immediate family has stock or stock options held in and serves as a consultant to or is an employee of Serica Technologies, Inc.

Reprint requests: Dr. Richmond, New England Baptist Hospital, 125 Parker Hill Avenue, Boston, MA 02120.

Perspectives on Modern Orthopaedics articles provide an objective appraisal of new or controversial techniques or areas of investigation in orthopaedic surgery.

The absence of adequate options to restore full knee joint function through anterior cruciate ligament reconstruction prompts the need to develop new ligament replacement strategies. Recent focus within the ligament engineering field has been on the establishment of appropriate anterior cruciate ligament graft design requirements and evaluation methods. A range of biomaterials and graft constructions has been explored in an attempt to identify the optimal ligament replacement. Thorough and standardized evaluation methods are required throughout all phases of development, from initial in vitro bench screening through a large animal in vivo model. The initial positive clinical, gross pathologic, histologic, and mechanical results from a 12-month in vivo goat study demonstrate the potential of bioengineered ligament devices.  




This article has been cited by other articles:


Home page
JBJSHome page
S. A. Maher, C. Hidaka, M. E. Cunningham, and S. A. Rodeo
What's New in Orthopaedic Research
J. Bone Joint Surg. Am., August 1, 2008; 90(8): 1800 - 1808.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Academy of Orthopaedic Surgeons.